The forecast for antacid medicine sales in Germany shows a steady growth trend from 2024 to 2028. In 2023, the market is estimated at approximately 40.2 million USD PPP. From 2024 to 2028, the year-on-year growth rates are slow but positive, demonstrating an incremental increase: 2% in 2024, 1.92% in 2025, 1.44% in 2026, 1.18% in 2027, and 0.93% in 2028. The compound annual growth rate (CAGR) over these five years is approximately 1.21%.
Future trends to watch for include potential disruptions from innovations in treatment, lifestyle shifts that might alter demand, and regulatory changes that could impact market dynamics.
